Home

autoreaktiver

Autoreaktiver refers to cells or immune responses that react against the body's own antigens. In immunology, the term is most often used for autoreactive lymphocytes, particularly T cells and B cells, that recognize self-components. These cells can arise during immune development, and although central tolerance mechanisms in the thymus and bone marrow delete many autoreactive clones, some escape elimination. Peripheral tolerance, including regulatory T cells and states of anergy, helps prevent these cells from causing harm under normal conditions.

Autoreactive responses are a central concept in autoimmune disease. When tolerance is breached or insufficient, autoreactive

Diagnosis and treatment implications focus on detecting autoimmune activity and modulating the immune response. Autoantibody testing

lymphocytes
can
attack
self-tissues,
leading
to
organ-specific
or
systemic
diseases.
Examples
include
autoreactive
T
cells
implicated
in
multiple
sclerosis
and
autoreactive
B
cells
producing
autoantibodies
in
diseases
such
as
systemic
lupus
erythematosus
or
rheumatoid
arthritis.
In
many
conditions,
autoantibodies
serve
as
useful
diagnostic
or
prognostic
markers,
while
autoreactive
T
cells
are
more
challenging
to
measure
directly
in
routine
clinical
practice.
(for
instance,
ANA,
anti-dsDNA,
or
anti-CCP)
supports
diagnosis
and
disease
monitoring.
Therapeutic
approaches
often
involve
immunosuppression
or
targeted
therapies
that
deplete
specific
immune
cell
populations,
such
as
B
cells,
with
the
aim
of
reducing
autoreactive
activity.
Ongoing
research
seeks
to
understand
how
autoreactive
cells
persist
in
health,
how
tolerance
fails,
and
how
antigen-specific
tolerance
can
be
induced.